manufacturing problems — e.g. “Disruption of the manufacture of the drug.” (Canada)
supply-chain disruption
— e.g. “Delay in shipping of the drug.” (Canada)
causes not stated by the regulator
Frequently asked questions
Is Buspirone Hydrochloride currently in shortage?
Yes. As of the latest regulator updates, Buspirone Hydrochloride has 5 active shortage notices across 1 country (Canada). Status is refreshed daily from official regulatory sources.
Why is Buspirone Hydrochloride in shortage?
Regulators attribute the current Buspirone Hydrochloride shortages to manufacturing problems, supply-chain disruption, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Buspirone Hydrochloride shortage be resolved?
Regulator-estimated resolution dates currently range from 6 Aug 2026 to 16 Aug 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Buspirone Hydrochloride shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.